Skip to main content

BRS1 — Neurotransmitter Regulation

BRS1(FM5) - Excitatory–Inhibitory Balance (GABA–Glutamate Regulation)

1. Definition

Functional control of excitatory–inhibitory tone through GABA–glutamate balance, supporting neural stability, inhibitory control, and resistance to overstimulation.

2. Functional Outcome Context

These outcomes describe translational contexts for the FM as an integrated biological capacity. They are not single-mechanism treatment claims. Confidence may increase where multiple child PMs converge on the same functional outcome.

No functional outcome context currently mapped.

3. Intervention Breakdown

Food-State Leaning

4. Functional Role

↑ inhibitory tone support; ↑ GABA synthesis support; ↑ glutamate control; ↑ excitation–inhibition balance

5. Mechanistic Basis (Integrated FM Narrative)

Excitatory–inhibitory balance emerges from the coordinated interaction of several primary mechanisms and supporting biological pools.

5.1 Core Primary Mechanisms

5.2 Supporting Biological Pools (Key Constraints)

5.3 Integrated Functional Narrative

Together, these PMs operationalise BRS1(FM5) as coordinated excitatory–inhibitory balance regulation.

5.4 Functional Failure Modes

Excitatory–inhibitory balance may weaken when amino acid quality & competitive balance declines or when reliance on incomplete protein sources without complementary pairing.

Reliance on incomplete protein sources without complementary pairing may reduce BRS1(KC2) — Amino Acid Quality & Competitive Balance. Chronically low indispensable amino-acid coverage across meals may further strain pool availability, lNAA imbalance favouring transport competition away from key precursors, ultra-processed low-protein dietary patterns, while inconsistent protein distribution across the day.

These pressures may impair BRS1-FM5-PM6 — GABA–Glutamate Neurotransmission Balance, weaken BRS1-FM5-PM7 — GABA Synthesis Capacity, reduce the effectiveness of BRS1-FM5-PM8 — Glutamate Clearance & Recycling, and compromise BRS1-FM5-PM9 — Excitotoxicity Modulation. At the FM level, this may shift BRS1(FM5) toward reduced excitatory–inhibitory balance performance.

6. Connected Mechanisms

  • BRS6-FM1-PM1 — Glycaemic Stability
  • BRS3-FM1-PM1 — Inflammatory Tone Regulation
  • BRS4-FM1-PM1 — Mitochondrial Bioenergetic Support

7. References

  1. Edden et al. (2012)
  2. Puts et al. (2020)
  3. Mamiya et al. (2021)
  4. Zhou and Danbolt (2014)